Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation (PTNM) System in Patients With OAB

NCT02857816 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.

NCT NCT02857816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02857816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation (PTNM) System in Patients With OAB
Lead sponsor
MedtronicNeuro
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2016
Completion date
November 21, 2017
Enrollment
154 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder